StonvexLoading…
StonvexCore line items from A's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $6.95B | $6.51B | $6.83B | $6.85B |
Operating Income | $1.48B | $1.49B | $1.35B | $1.62B |
Net Income | $1.30B | $1.29B | $1.24B | $1.25B |
EPS (Diluted) | $4.57 | $4.43 | $4.19 | $4.18 |
Total Assets | $12.73B | $11.85B | $10.76B | $10.53B |
Total Liabilities | $5.99B | $5.95B | $4.92B | $5.23B |
Cash & Equivalents | $1.79B | $1.33B | $1.59B | $1.05B |
Free Cash Flow OCF − CapEx | $1.15B | $1.37B | $1.47B | $1.02B |
Shares Outstanding | 283.05M | 285.19M | 292.12M | 295.26M |